Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis
Authors:
- 1 September 2016
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 306, 58-68
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81273526, 81473268)
- Anhui provincial key scientific and technological project (1301042212)
- Anhui Provincial Natural Science Foundation (1308085MH145)
This publication has 47 references indexed in Scilit:
- The HDAC interaction networkMolecular Systems Biology, 2013
- Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblastsCell Death & Disease, 2013
- Myofibroblasts revert to an inactive phenotype during regression of liver fibrosisProceedings of the National Academy of Sciences, 2012
- Methamphetamine Causes Differential Alterations in Gene Expression and Patterns of Histone Acetylation/Hypoacetylation in the Rat Nucleus AccumbensPLOS ONE, 2012
- Epigenetic cell fate regulation of hepatic stellate cellsHepatology Research, 2011
- Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancerGenome Research, 2010
- Mammalian Sirtuins: Biological Insights and Disease RelevanceAnnual Review of Pathology: Mechanisms of Disease, 2010
- HDAC expression and clinical prognosis in human malignanciesCancer Letters, 2009
- Isoform-selective histone deacetylase inhibitorsChemical Society Reviews, 2008
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008